Carla Gaggiano, Anna Maselli, Petros P Sfikakis, Katerina Laskari, Gaafar Ragab, Mohamed Tharwat Hegazy, Ahmed Hatem Laymouna, Giuseppe Lopalco, Ibrahim A Almaghlouth, Kazi Nur Asfina, Ohoud Alahmed, Henrique Ayres Giardini Mayrink, Isabele Parente de Brito Antonelli, Marco Cattalini, Matteo Piga, Jurgen Sota, Stefano Gentileschi, Maria Cristina Maggio, Daniela Opris-Belinski, Gülen Hatemi, Antonella Insalaco, Alma Nunzia Olivieri, Abdurrahman Tufan, Hazan Karadeniz, Riza Can Kardaş, Francesco La Torre, Fabio Cardinale, Achille Marino, Silvana Guerriero, Piero Ruscitti, Maria Tarsia, Antonio Vitale, Valeria Caggiano, Salvatore Telesca, Florenzo Iannone, Veronica Parretti, Micol Frassi, Emma Aragona, Francesco Ciccia, Ewa Wiesik-Szewczyk, Ruxandra Ionescu, Ali Şahin, Nurullah Akkoç, Andrea Hinojosa-Azaola, Samar Tharwat, José Hernández-Rodríguez, Gerard Espinosa, Giovanni Conti, Emanuela Del Giudice, Marcello Govoni, Giacomo Emmi, Claudia Fabiani, Alberto Balistreri, Bruno Frediani, Donato Rigante, Luca Cantarini
This study aims to describe musculoskeletal manifestations (MSM) in children with Behçet's syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behçet's Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67...
March 7, 2023: Internal and Emergency Medicine